Shire HGT, a business unit of global specialty biopharmaceutical company Shire plc, is committed to collaborating with academic researchers, health care professionals, and patient associations around the world.
Our shared goal is a deeper understanding of life-altering genetic disorders. Our work together includes the investigation and development of therapeutic approaches in rare genetic diseases.
For more information about Shire, visit our corporate Web site at www.shire.com.
OnePathSM will serve as an initial point of contact for physicians interested in the protocol. OnePathSM will be directing inquiries to appropriate clinical trial management personnel.
If you are a physician and are interested in finding out more information, please contact our OnePathsm services at 1-866-888-0660
For more information
Get updates by email:
* Required